Drupal.behaviors.print = function(context) {window.print();window.close();}>
PEPFAR Invests Additional $11M to Supply Cepheid TB Test in 14 High-burden Countries
December 06, 2012
PEPFAR Invests Additional $11M to Supply Cepheid TB Test in 14 High-burden Countries
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Cepheid Plans to Buy Plastics Firm, Signs Second Agreement to Increase Adoption of TB Test
September 28, 2012 / GenomeWeb Daily News
China's Zeesan Biotech Developing Portfolio of Melt Curve MDx Assays after SFDA Approves TB Tests
April 25, 2013 / PCR Insider
Cepheid, OHSU Co-developing Cancer MDx Tests for GeneXpert
February 19, 2013 / GenomeWeb Daily News
In Cepheid v. Roche IP Suit, Court Delays Hearing on One Patent, Dismisses Second Patent from Case
January 18, 2013 / GenomeWeb Daily News
Cepheid Xpert CT/NG Gets CLIA 'Moderate Complexity' Rating
January 15, 2013 / GenomeWeb Daily News